International law firm Dorsey & Whitney LLP is pleased to announce that Partner and Beijing Office Head Ray Liu has been named to China Business Law Journal’s 2020 A-List of elite China lawyers.

The list is based on extensive research conducted by the China Business Law Journal and features “200 elite lawyers for China practice” including 100 lawyers working in PRC law firms and 100 lawyers in foreign ones.

To identify the lawyers for the Chinese market, China Business Law Journal surveyed thousands of in-house counsel in China and around the world, as well as partners at Chinese and international law firms. Nominations were received from professionals at a wide range of Chinese and international companies, law firms and other organizations. The final list reflects the nominations received combined with the China Business Law Journal editorial team's years of collective experience in documenting and analyzing China's legal market.

The full A-List is available at China Business Law Journal.

Ray Liu is a global partner and office head of Dorsey’s Beijing Office, qualified to practise in both the State of New York and China. Liu concentrates on cross-border dispute resolution, US litigation, international and foreign-related arbitration, cross-border investigations and compliance matters. His practice areas also include cross-border investment and international trade, foreign direct investment, general corporate and M&A.

He has advised on a wide variety of industries including banking, insurance, asset management, TMT, intelligent manufacturing, food and agriculture, chemicals and materials, mining and energy, medical and biotech, and infrastructure. Before joining Dorsey, he worked for the legal department at the New York branch of a major Chinese bank in New York city.

Liu has represented a number of high-profile US litigations, international arbitrations, criminal and government investigations, overseas compliance matters, cross-border transactions and negotiation matters, which have earned him great praise and deep trust from his state-owned enterprise, unicorn, multinational and high-profile individual clients.

For instance, he represented a major creditor in the chapter 11 US bankruptcy case filed by JIA Yueting. He represented major international Chinese banks in high-profile anti-money laundering and counter-terrorist financing cases, and managed and completed one of the largest US e-discovery and document review projects to date in China. He represented a major Chinese international insurance company, and its insureds, in numerous major product liability, wrongful death and coverage cases in North America. He represented a Chinese company and its executives in a US securities litigation, and (in the first such case) helped the company and its executives obtain a complete dismissal of the lawsuit, and also collect damages and legal fees from the plaintiff firm. He also represented leading Chinese academics in filing an amicus brief in the high-profile Vitamin C antitrust litigation case before the US Supreme Court.

Liu is frequently invited to attend and deliver keynote speeches at major international investment, economic and legal forums and seminars, and is involved in teaching at Chinese bar associations, and in continuing legal education courses in the US. He is also frequently interviewed by the People’s Daily and The New York Times newspapers, and invited to comment on US-China legal and economic issues that are widely covered by mainstream media.

Liu graduated from Vanderbilt University Law School, and China University of Political Science and Law (CUPL). He received CUPL’s Outstanding Alumni Award, and is an adjunct tutor of the Master of Laws School of CUPL and a director of the CUPL International Law School Alumni Association.

Dorsey’s U.S.-China Practice Group, which includes nearly 30 lawyers in nine Dorsey offices in Asia and across the United States and represents some of China’s largest and most active corporations, including top financial institutions – such as banks and insurance companies – and private equity funds, as well as high net-worth individuals and family offices.